This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree
Published . Updated .
RA Capital has already participated in four biotech financings in September. Meanwhile, Janus Henderson has been the year's most prolific backer of biotech reverse merger deals, according to Gilmartin Group.
Directly affected
- No company is named in this report.
Indirectly affected
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DVA DaVita HealthCare Partners, Inc.
GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- GEHC GE HEALTHCARE TECHNOLOGIES I
GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
RA Capital has already participated in four biotech financings in September. Meanwhile, Janus Henderson has been the year's most prolific backer of biotech reverse merger deals, according to Gilmartin Group.
Source: BioPharma Dive
Who reported a Acadia Healthcare (ACHC) trade near this story
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 17 days after publication, inside 30 days. The filing is listed beside the story “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 1 days before publication, inside 30 days. The filing is listed beside the story “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 40 days before publication, inside 60 days. The filing is listed beside the story “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 44 days before publication, inside 60 days. The filing is listed beside the story “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 44 days before publication, inside 60 days. The filing is listed beside the story “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 51 days before publication, inside 60 days. The filing is listed beside the story “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 53 days before publication, inside 60 days. The filing is listed beside the story “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree.”
- Donald J Trump sell GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 57 days before publication, inside 60 days. The filing is listed beside the story “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Acadia Healthcare (ACHC)
Companies tied to this story
- ACHC Acadia Healthcare
Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence in the 12 Sep 2026 story “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree.” Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence in the 12 Sep 2026 story “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree.” Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
In “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree,” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence in the 12 Sep 2026 story “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree.” Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
Davita (DVA) is linked, with no stored direction, medium confidence in the 12 Sep 2026 story “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree.” Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- GEHC GE HealthCare Technologies
In “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree,” GE HealthCare Technologies (GEHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Acadia Healthcare (ACHC)
The 12 Sep 2026 story “This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree” names Acadia Healthcare (ACHC) because of this story.
For Acadia Healthcare (ACHC), the reason on file says GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Ascendis Pharma A/S (ASND) is here too. Its reason reads: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
What the saved facts support for Acadia Healthcare (ACHC)
46 out of 100
“This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.